177 related articles for article (PubMed ID: 20175591)
21. Premenstrual dysphoria and the serotonin system: pathophysiology and treatment.
Steiner M; Pearlstein T
J Clin Psychiatry; 2000; 61 Suppl 12():17-21. PubMed ID: 11041380
[TBL] [Abstract][Full Text] [Related]
22. Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo.
Pearlstein TB; Halbreich U; Batzar ED; Brown CS; Endicott J; Frank E; Freeman EW; Harrison WM; Haskett RF; Stout AL; Yonkers KA
J Clin Psychiatry; 2000 Feb; 61(2):101-9. PubMed ID: 10732657
[TBL] [Abstract][Full Text] [Related]
23. Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder.
Freeman EW
CNS Drugs; 2004; 18(7):453-68. PubMed ID: 15139800
[TBL] [Abstract][Full Text] [Related]
24. Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder.
Trivedi MH; Wan GJ; Mallick R; Chen J; Casciano R; Geissler EC; Panish JM
J Clin Psychopharmacol; 2004 Oct; 24(5):497-506. PubMed ID: 15349005
[TBL] [Abstract][Full Text] [Related]
25. Selective serotonin reuptake inhibitors for premenstrual syndrome.
Marjoribanks J; Brown J; O'Brien PM; Wyatt K
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001396. PubMed ID: 23744611
[TBL] [Abstract][Full Text] [Related]
26. Fluoxetine in the treatment of premenstrual dysphoric disorder.
Carr RR; Ensom MH
Ann Pharmacother; 2002 Apr; 36(4):713-7. PubMed ID: 11918525
[TBL] [Abstract][Full Text] [Related]
27. Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial.
Yonkers KA; Kornstein SG; Gueorguieva R; Merry B; Van Steenburgh K; Altemus M
JAMA Psychiatry; 2015 Oct; 72(10):1037-44. PubMed ID: 26351969
[TBL] [Abstract][Full Text] [Related]
28. SSRIs for premenstrual dysphoric disorder.
Drug Ther Bull; 2002 Sep; 40(9):70-2. PubMed ID: 12298224
[TBL] [Abstract][Full Text] [Related]
29. Premenstrual dysphoric disorder in adolescents: case reports of treatment with fluoxetine and review of the literature.
Silber TJ; Valadez-Meltzer A
J Adolesc Health; 2005 Dec; 37(6):518-25. PubMed ID: 16310133
[TBL] [Abstract][Full Text] [Related]
30. A cost-effective approach to the use of selective serotonin reuptake inhibitors in a Veterans Affairs Medical Center.
Singletary T; North DS; Weiss M; Marman G
Am J Manag Care; 1997 Jan; 3(1):125-9. PubMed ID: 10169244
[TBL] [Abstract][Full Text] [Related]
31. Cost-utility of selective serotonin reuptake inhibitors for depression in primary care in Catalonia.
Serrano-Blanco A; Pinto-Meza A; Suárez D; Peñarrubia MT; Haro JM;
Acta Psychiatr Scand Suppl; 2006; (432):39-47. PubMed ID: 17087814
[TBL] [Abstract][Full Text] [Related]
32. [Sertraline in the treatment of premenstrual dysphoric disorder].
Culav-Sumić J; Skocilić Z; Jukić V
Lijec Vjesn; 1999; 121(7-8):234-8. PubMed ID: 10573958
[TBL] [Abstract][Full Text] [Related]
33. Differences in symptom scores and health outcomes in premenstrual syndrome.
Borenstein JE; Dean BB; Leifke E; Korner P; Yonkers KA
J Womens Health (Larchmt); 2007 Oct; 16(8):1139-44. PubMed ID: 17937566
[TBL] [Abstract][Full Text] [Related]
34. Treatment of premenstrual dysphoric disorder with the GABA
Bixo M; Ekberg K; Poromaa IS; Hirschberg AL; Jonasson AF; Andréen L; Timby E; Wulff M; Ehrenborg A; Bäckström T
Psychoneuroendocrinology; 2017 Jun; 80():46-55. PubMed ID: 28319848
[TBL] [Abstract][Full Text] [Related]
35. What's Stopping Us? Using GnRH Analogs With Stable Hormone Addback in Treatment-Resistant Premenstrual Dysphoric Disorder: Practical Guidelines and Risk-Benefit Analysis for Long-term Therapy.
Wagner-Schuman M; Kania A; Barone JC; Ross JM; Mulvihill A; Eisenlohr-Moul TA
J Clin Psychiatry; 2023 Jun; 84(4):. PubMed ID: 37341478
[No Abstract] [Full Text] [Related]
36. Treatment of premenstrual dysphoric disorder (PMDD) with a novel formulation of drospirenone and ethinyl estradiol.
De Berardis D; Serroni N; Salerno RM; Ferro FM
Ther Clin Risk Manag; 2007 Aug; 3(4):585-90. PubMed ID: 18472980
[TBL] [Abstract][Full Text] [Related]
37. Oral contraceptives containing drospirenone for premenstrual syndrome.
Lopez LM; Kaptein AA; Helmerhorst FM
Cochrane Database Syst Rev; 2009 Apr; (2):CD006586. PubMed ID: 19370644
[TBL] [Abstract][Full Text] [Related]
38. Oral contraceptives containing drospirenone for premenstrual syndrome.
Lopez LM; Kaptein A; Helmerhorst FM
Cochrane Database Syst Rev; 2008 Jan; (1):CD006586. PubMed ID: 18254106
[TBL] [Abstract][Full Text] [Related]
39. Rapid response to fluoxetine in women with premenstrual dysphoric disorder.
Steinberg EM; Cardoso GM; Martinez PE; Rubinow DR; Schmidt PJ
Depress Anxiety; 2012 Jun; 29(6):531-40. PubMed ID: 22565858
[TBL] [Abstract][Full Text] [Related]
40. Treatment of premenstrual disorders.
Kroll R; Rapkin AJ
J Reprod Med; 2006 Apr; 51(4 Suppl):359-70. PubMed ID: 16734319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
